NASDAQ:SLGL Sol-Gel Technologies Q3 2025 Earnings Report $72.00 -1.00 (-1.37%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$71.90 -0.11 (-0.15%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Sol-Gel Technologies EPS ResultsActual EPS-$2.13Consensus EPS -$2.09Beat/MissMissed by -$0.04One Year Ago EPSN/ASol-Gel Technologies Revenue ResultsActual Revenue$0.40 millionExpected Revenue$0.30 millionBeat/MissBeat by +$100.00 thousandYoY Revenue GrowthN/ASol-Gel Technologies Announcement DetailsQuarterQ3 2025Date11/20/2025TimeBefore Market OpensConference Call DateThursday, November 20, 2025Conference Call Time8:30AM ETUpcoming EarningsSol-Gel Technologies' Q3 2026 earnings is estimated for Thursday, November 19, 2026, based on past reporting schedulesConference Call ResourcesPress Release (6-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(6-K) Sol-Gel Technologies Earnings HeadlinesSol-Gel Technologies consensus price target decreased by 22.46% to $155.55October 2 at 12:31 AM | msn.comSol-Gel Technologies Ltd. (NASDAQ:SLGL) Receives Average Rating of "Moderate Buy" from BrokeragesOctober 1 at 6:15 AM | americanbankingnews.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.October 3 at 1:00 AM | Reagan Gold Group (Ad)Sol-Gel Technologies Sets October 14 KOL Investor Day for SGT-610September 30 at 9:31 AM | tipranks.comSol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026September 30 at 9:14 AM | globenewswire.comComparing Heron Therapeutics (NASDAQ:HRTX) and Sol-Gel Technologies (NASDAQ:SLGL)September 23, 2026 | americanbankingnews.comSee More Sol-Gel Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email. Email Address About Sol-Gel TechnologiesSol-Gel Technologies (NASDAQ:SLGL) is an Israeli specialty pharmaceutical company focused on developing topical dermatological treatments. The company uses proprietary microencapsulation technology designed to improve the delivery, stability, and tolerability of active pharmaceutical ingredients applied to the skin. Sol-Gel’s products include TWYNEO Cream, a topical combination of tretinoin and benzoyl peroxide for acne, and EPSOLAY Cream, a microencapsulated benzoyl peroxide treatment for inflammatory lesions associated with rosacea. Both products have received approval from the U.S. Food and Drug Administration and are commercialized in the United States through a licensing arrangement with Galderma. Founded in 1997 and headquartered in Ness Ziona, Israel, Sol-Gel Technologies serves the dermatology market primarily through partnerships supporting the development and commercialization of its prescription products. The company also continues to develop additional topical treatments using its proprietary drug-delivery platform.View Sol-Gel Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes Next Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
